Indication
Melasma
14 clinical trials
22 products
1 drug
Product
Group CYSClinical trial
Randomized Controlled Investigator Blinded Comparative Study of the Efficacy and Tolerability of Test Product Versus Cysteamine 5% in the Treatment of Facial Epidermal Melasma Over 4 MonthsStatus: Recruiting, Estimated PCD: 2024-06-01
Clinical trial
A Randomized, Controlled, Single Center Clinical Study to Evaluate the Effect of Facial Serum Q69 in Moderating the Appearance of Mild to Moderate MelasmaStatus: Completed, Estimated PCD: 2022-02-25
Product
HydroquinoneClinical trial
Efficiency And Safety Of Association Arbutin, Triamcinolone And Tretinoin In The Treatment Of Facial Melasma, Taking As Reference The Product Triluma ® (Hidroquinone, Fluoncinolone And Tretinoin).Status: , Estimated PCD: 2008-07-01
Product
ArbutinProduct
TrilumaClinical trial
Oral Isotretinoin in The Treatment of Melasma A Randomized Controlled Clinical TrialStatus: Recruiting, Estimated PCD: 2024-01-31
Product
IsotretinoinProduct
Triple combination formulaClinical trial
The Effectiveness of 3% Topical Tranexamic Acid Compared to 4% Topical Hydroquinone as Therapy of MelasmaStatus: Active (not recruiting), Estimated PCD: 2023-09-01
Product
Topical Tranexamic AcidProduct
Topical HidroquinoneClinical trial
Effectiveness of Curcuma Xanthorriza Roxb. 10% Cream in Reducing Melasma Area and Severity Index (MASI) Scores and Improvement of Skin Brightness in Epidermal Type MelasmaStatus: Recruiting, Estimated PCD: 2024-02-22
Product
Curcuma xanthorriza RoxbProduct
2% Kojic AcidClinical trial
Comparison Of The Efficacy Of Combination Of TAM Formula Versus Kligman Formula For Melasma At Tertiary Care Hospital,Karachi.Status: Active (not recruiting), Estimated PCD: 2022-12-01
Product
TAM formulaProduct
Kligman formulaClinical trial
Compare the Efficacy and Safety Profile of Cysteamine and Hydroquinone in Melasma as Topical ApplicationStatus: Completed, Estimated PCD: 2020-09-11
Product
CysteamineProduct
Hydroquinone creamClinical trial
The Boosting Effect of Hyaluronic Acid on Tranexamic Acid Microneedles in Melasma Patients: A Split- Face StudyStatus: Not yet recruiting, Estimated PCD: 2023-11-01
Product
Tranexamic acidClinical trial
Comparative Efficacy of Azelaic Acid 20% Cream Versus Hydroquinone 4% Cream as an Adjuvant to Oral Tranexamic Acid in MelasmaStatus: Completed, Estimated PCD: 2023-04-30
Product
Group B Azelaic AcidClinical trial
Comparison of 30% Metformin and 2% Nicotinamide Lotion With Kligman Formula in the Treatment of MelasmaStatus: Completed, Estimated PCD: 2023-02-15
Clinical trial
Comparative Efficacy of Intralesional Tranexamic Acid and Platelets Rich Plasma in the Treatment of MelasmaStatus: Completed, Estimated PCD: 2023-04-30
Product
Platelets rich plasmaClinical trial
The Efficacy in Treatment of Facial Melasma Combined With Thulium 1927-nm Fractional Laser and Topical H2R Antagonist: a Split-face, Single-blind StudyStatus: Completed, Estimated PCD: 2023-11-25
Product
Topical H2R AntagonistClinical trial
A Randomized, Observer-Blinded, Placebo-Controlled Study on the Safety and Efficacy of Twice Daily Application of SM-030 Gel 0.64% Vs. SM-030 Gel 0.08% Vs. Placebo Gel in Adults With MelasmaStatus: Recruiting, Estimated PCD: 2025-01-01
Product
SM-030Drug
Varlilumab